Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Spinozzi

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Human Gene Therapy|July 20, 2016
Preclinical Testing of the Safety and Tolerability of Lentiviral Vector-Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice StudiesIlaria Visigalli, Stefania Delai, Francesca Ferro, et al.
Leukemia|February 14, 2019
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutationsPaolo Sportoletti, Letizia Celani, Emanuela Varasano, et al.
Blood|February 15, 2023
Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in miceAndrea Calabria, Carlo Cipriani, Giulio Spinozzi, et al.
Blood Advances|August 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AMLGiulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2023
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cellsErika Valeri, Giulia Unali, Francesco Piras, et al.
Nature Medicine|June 18, 2021
Retrieval of vector integration sites from cell-free DNADaniela Cesana, Andrea Calabria, Laura Rudilosso, et al.
Leukemia|November 7, 2020
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in micePaolo Sportoletti, Daniele Sorcini, Anna G Guzman, et al.
Blood Advances|December 15, 2022
IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AMLVincenzo Maria Perriello, Maria Caterina Rotiroti, Ilaria Pisani, et al.
Leukemia|March 3, 2021
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AMLIlaria Gionfriddo, Lorenzo Brunetti, Federica Mezzasoma, et al.
Nature|October 23, 2024
Long-term lineage commitment in haematopoietic stem cell gene therapyAndrea Calabria, Giulio Spinozzi, Daniela Cesana, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Human Gene Therapy|July 20, 2016
Preclinical Testing of the Safety and Tolerability of Lentiviral Vector-Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice StudiesIlaria Visigalli, Stefania Delai, Francesca Ferro, et al.
Leukemia|February 14, 2019
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutationsPaolo Sportoletti, Letizia Celani, Emanuela Varasano, et al.
Blood|February 15, 2023
Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in miceAndrea Calabria, Carlo Cipriani, Giulio Spinozzi, et al.
Blood Advances|August 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AMLGiulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2023
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cellsErika Valeri, Giulia Unali, Francesco Piras, et al.
Nature Medicine|June 18, 2021
Retrieval of vector integration sites from cell-free DNADaniela Cesana, Andrea Calabria, Laura Rudilosso, et al.
Leukemia|November 7, 2020
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in micePaolo Sportoletti, Daniele Sorcini, Anna G Guzman, et al.
Blood Advances|December 15, 2022
IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AMLVincenzo Maria Perriello, Maria Caterina Rotiroti, Ilaria Pisani, et al.
Leukemia|March 3, 2021
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AMLIlaria Gionfriddo, Lorenzo Brunetti, Federica Mezzasoma, et al.
Nature|October 23, 2024
Long-term lineage commitment in haematopoietic stem cell gene therapyAndrea Calabria, Giulio Spinozzi, Daniela Cesana, et al.
Pageof 3